NSPR Message Board Post 12248156 | InspireMD Inc.
home / stock / nspr / nspr message board
luthererceg
(investorshub)
Posted on: Apr/19/2023 03:43:01
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166580343
Good read
News, Short Squeeze, Breakout and More Instantly...
-
- Generated first quarter 2024 CGuard EPS revenue of $1.51 million, an increase of 22.0% over the first quarter of 2023 - - Announced that an abstract detailing one-year outcomes from the C-GUARDIANS IDE clinical trial of CGuard™ Prime has been accepted for presentation at LINC 2...
-
TEL AVIV, Israel and MIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease and stroke prevention, announced today it will report first quarter 2024 financial ...